WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer Inc., a global leader focused on the health and safety of people and the environment, today announced the launch of the Solaris™ quantitative optical molecular imaging system. This preclinical solution for use in small and large animal studies will help to advance drug discovery and translational research to develop and validate molecular-guided surgical research protocols.
The Solaris system, when combined with PerkinElmer’s suite of fluorescence molecular imaging probes, can bridge molecular imaging research techniques to support potential clinical outcomes. By distinguishing healthy versus diseased tissue in real-time, researchers can more accurately and completely map tumors.
Help employers find you! Check out all the jobs and post your resume.
